Abnormal left ventricular energy metabolism in obese men with preserved systolic and diastolic functions is associated with insulin resistance

Diabetes Care

Volumn 30, Issue 6, 2007, Pages 1520-1526

  Perseghin, Gianluca ^a,b   Ntali, Georgia ^a   De Cobelli, Francesco ^a   Lattuada, Guido ^a   Esposito, Antonio ^a   Belloni, Elena ^a   Canu, Tamara ^a   Costantino, Federica ^a   Ragogna, Francesca ^a   Scifo, Paola ^a   Del Maschio, Alessandro ^a,c   Luzi, Livio ^a,b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIASTOLE; ENERGY METABOLISM; HEART FUNCTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE MASS; HEART VOLUME; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; METABOLIC SYNDROME X; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; SMOKING; SYSTOLE;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; BODY SIZE; DIASTOLE; ENERGY METABOLISM; HUMANS; INSULIN; INSULIN RESISTANCE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OBESITY; REFERENCE VALUES; SYSTOLE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 34249903324     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-2429     Document Type: Article

References (31)

1. Schernthaner G: Cardiovascular mortality and morbidity in type 2 diabetes mellitus. Diabetes Res Clin Pract 31:S3-S13, 1996
2. Kannel WB, Hjortland M, Castelli WP: Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 34:29-34, 1974
3. Picano E: Diabetic cardiomyopathy: the importance of being earliest. J Am Coll Cardiol 42:454-457, 2003
4. Taegtmeyer H, McNulty P, Young ME: Adaptation and maladaptation of the heart in diabetes. I. General concepts. Circulation 105:1727-33, 2002
5. Taegtmeyer H, Razeghi P: Heart disease in diabetes: resist the beginnings (Editorial). J Am Coll Cardiol 43: 315, 2004
6. Scheuermann-Freestone M, Madsen PL, Manners D, Blamire AM, Buckingham RE, Styles P, Radda GK, Neubauer S, Clarke K: Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes. Circulation 107:3040-3046, 2003
7. Diamant M, Lamb HJ, Groeneveld Y, Endert EL, Smit JW, Bax JJ, Romijn JA, de Roos A, Radder JK: Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus. J Am Coll Cardiol 42:328-335, 2003
8. Baecke JAH, Burema J, Frijters JER: A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 36:936-942, 1982
9. 13C NMR spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes 48:1600-1606, 1999
10. Lattuada G, Costantino F, Caumo A, Ragogna F, Scifo P, De Cobelli F, Del Maschio A, Luzi L, Perseghin G: Reduced whole body lipid oxidation is associated with insulin resistance but not with intramyocellular lipid content in offspring of type 2 diabetic patients. Diabetologia 48:741-747, 2005
11. 31P-MRS study. J Am Coll Cardiol 46:1085-1092, 2005
12. Chia JM, Fischer SE, Wickline SA, Lorenz CH: Performance of QRS detection for cardiac magnetic resonance imaging with a novel vectorcardiographic triggering method. J Magn Reson Imaging 12:678-688, 2000
13. De Roos A, Doornbos J, Luyten PR, Oosterwaal LJMP, van der Wall EE, den Hollander JA: Cardiac metabolism in patients with dilated and hypertrophic cardiomyopathy: assessment with proton-decoupled P-31 MR spectroscopy. J Magn Reson Imaging 2:711-719, 1992
14. Lamb HJ, Beyerbacht HP, Ouwerkerk R, Doornbos J, Pluim BM, van der Wall EE, van der Laarse A, de Roos A: Metabolic response of normal human myocardium to high dose atropine-dobutamine stress studied by 31P-MRS. Circulation 96:2969-2977, 1997
15. Lamb HJ, Doornbos J, den Hollander JA, Luyten PR, Beyerbacht HP, van der Wall EE, de Roos A: Reproducibility of human cardiac 31P-NMR spectroscopy. NMR Biomed 9:217-227, 1996
16. Wallace TM, Levy JC, Matthews DR: Use and abuse of HOMA modeling. Diabetes Care 27:1487-1495, 2004
17. Lamb HJ, Beyerbacht HP, van der Laarse A, Stoel BC, Doornbos J, van der Wall EE, de Roos A: Diastolic dysfunction in hypertensive heart disease is associated with altered myocardial metabolism. Circulation 99:2261-2267, 1999
18. Nakae I, Mitsunami K, Omura T, Yabe T, Tsutamoto T, Matsuo S, Takahashi M, Morikawa S, Inubushi T, Nakamura Y, Kinoshita M, Horie M: Proton magnetic resonance spectroscopy can detect creatine depletion associated with the progression of heart failure in cardiomyopathy. J Am Coll Cardiol 42:1587-1593, 2003
19. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F; American Heart Association; National Heart, Lung, and Blood Institute: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112:2735-2752, 2005
20. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI: Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350:664-671, 2004
21. Szczepaniak LS, Dobbins RL, Metzger GJ, Sartoni-D'Ambrosia G, Arbique D, Vongpatanasin W, Unger R, Victor RG: Myocardial triglycerides and systolic function in humans: in vivo evaluation by localized proton spectroscopy and cardiac imaging. Magn Reson Med 49 :417-423, 2003
22. Reingold JS, McGavock JM, Kaka S, Tillery T, Victor RG, Szczepaniak LS: Determination of triglyceride in the human myocardium by magnetic resonance spectroscopy: reproducibility and sensitivity of the method. Am J Physiol Endocrinol Metab 289:E935-E939, 2005
23. Sharma S, Adrogue JV, Golfman L, Uray I, Lemm J, Youker K, Noon GP, Frazier OH, Taegtmeyer H: Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEB J 18:1692-1700, 2004
24. Kankaanpaa M, Lehto H-R, Parkka JP, Komu M, Viljanen A, Ferrannini E, Knuuti J, Nuutila P, Parkkola R, Iozzo P: Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels. J Clin Endocrinol Metab 91:4689-4695, 2006
25. Goodwin GW, Taylor CS, Taegtmayer H: Regulation of energy metabolism of the heart during acute increase in heart work. J Biol Chem 273:29530-29539, 1998
26. How O-J, Aasum E, Severson DL, Chan WYA, Faadiel Essop M, Larsen TS: Increased myocardial oxygen consumption reduces cardiac efficiency in diabetic mice. Diabetes 55:466-473, 2006
27. Fragasso G, Perseghin G, De Cobelli F, Esposito A, Palloshi A, Lattuada G, Scifo P, Calori G, Del Maschio A, Margonato A: Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure. Eur Heart J 27:942-948, 2006
28. Taegtmeyer H: Cardiac metabolism as a target for the treatment of heart failure. Circulation 110:894-896, 2004
29. Peterson LR, Herrero P, Schechtman KB, Racette SB, Waggoner AD, Kisrieva-Ware Z, Dence C, Klein S, Marsala J, Meyer T, Gropler RJ: Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women. Circulation 109:2191-2196, 2004
30. Caumo A, Perseghin G, Brunani A, Luzi L: New insights on the simultaneous assessment of insulin sensitivity and β-cell function with the HOMA2 method. Diabetes Care 29:2733-2734, 2006
31. Palmon LC, Reichek N, Yeon SB, Clark NR, Brownson D, Hoffman E, Axel L: Intramural myocardial shortening in hypertensive left ventricular hypertrophy with normal pump function. Circulation 89:122-131, 1994